These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
330 related items for PubMed ID: 2784659
1. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus. Charlesworth JA, Peake PW, Golding J, Mackie JD, Pussell BA, Timmermans V, Wakefield D. Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659 [Abstract] [Full Text] [Related]
2. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus. Nguyen CP, Cao VV, Fehér J, Gergely P. Acta Med Hung; 1988 Feb; 45(2):145-59. PubMed ID: 3266790 [Abstract] [Full Text] [Related]
5. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus. Garabet L, Gilboe IM, Mowinckel MC, Jacobsen AF, Mollnes TE, Sandset PM, Jacobsen EM. Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178 [Abstract] [Full Text] [Related]
6. The metabolism of C3 and C4 in patients with immune complexes and normal complement levels. Charlesworth JA, Peake PW, Golding J, Pussell BA, Timmermans V, Wicks I, Wakefield D. Aust N Z J Med; 1989 Apr; 19(2):118-24. PubMed ID: 2764813 [Abstract] [Full Text] [Related]
7. Complement (C3) metabolism in systemic lupus erythematosus in relation to the disease course. Swaak AJ, van Rooyen A, Vogelaar C, Pillay M, Hack E. Rheumatol Int; 1986 Apr; 6(5):221-6. PubMed ID: 3492026 [Abstract] [Full Text] [Related]
8. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity. Kim AHJ, Strand V, Sen DP, Fu Q, Mathis NL, Schmidt MJ, Bruchas RR, Staten NR, Olson PK, Stiening CM, Atkinson JP. Arthritis Rheumatol; 2019 Mar; 71(3):420-430. PubMed ID: 30294950 [Abstract] [Full Text] [Related]
15. The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus. Miyawaki S, Nishiyama S, Aita T, Yoshinaga Y. Mod Rheumatol; 2013 Jul; 23(4):659-66. PubMed ID: 23011357 [Abstract] [Full Text] [Related]
16. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus. Thanadetsuntorn C, Ngamjanyaporn P, Setthaudom C, Hodge K, Saengpiya N, Pisitkun P. Sci Rep; 2018 Feb 08; 8(1):2620. PubMed ID: 29422675 [Abstract] [Full Text] [Related]
17. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Lloyd W, Schur PH. Medicine (Baltimore); 1981 May 08; 60(3):208-17. PubMed ID: 7231154 [Abstract] [Full Text] [Related]
19. Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus. Li H, Lin S, Yang S, Chen L, Zheng X. Clin Rheumatol; 2015 Mar 08; 34(3):471-7. PubMed ID: 25597615 [Abstract] [Full Text] [Related]